Table 2.
Patient clinicopathological characteristics according to the Eg5 score.
| Characteristic | n | Eg5 expression, n (%) | Pearson χ2 | p | |
|---|---|---|---|---|---|
| Negative | Positive | ||||
| Total | 156 | 51 (32.69) | 105 (67.31) | ||
| Gender | 0.132 | 0.717 | |||
| Male | 119 | 38 (31.93) | 81 (68.07) | ||
| Female | 37 | 13 (35.14) | 24 (64.86) | ||
| Age | 1.867 | 0.172 | |||
| <60 | 109 | 39 (35.78) | 70 (64.22) | ||
| ≥60 | 45 | 11 (24.44) | 34 (75.56) | ||
| Unknown | 2 | ||||
| Differentiation | 2.092 | 0.351 | |||
| Well | 12 | 6 (50.00) | 6 (50.00) | ||
| Middle | 113 | 34 (30.09) | 79 (69.91) | ||
| Poor | 31 | 11 (35.48) | 20 (64.52) | ||
| Liver cirrhosis | 4.298 | 0.038∗ | |||
| Yes | 99 | 26 (26.26) | 73 (73.74) | ||
| No | 46 | 20 (43.48) | 26 (56.52) | ||
| Unknown | 11 | ||||
| Gross classification | 0.093 | 0.760 | |||
| Solitary | 139 | 46 (33.09) | 93 (66.91) | ||
| Multiple | 17 | 5 (29.41) | 12 (70.59) | ||
| Hepatitis B viral infection | 1.115 | 0.291 | |||
| Yes | 12 | 2 (16.67) | 10 (83.33) | ||
| No | 128 | 39 (30.47) | 89 (69.53) | ||
| Unknown | 16 | ||||
| Vascular invasion | 2.121 | 0.145 | |||
| Yes | 68 | 18 (26.47) | 50 (73.53) | ||
| No | 88 | 33 (37.50) | 55 (62.50) | ||
| Tumor diameter | 1.974 | 0.160 | |||
| <5 cm | 93 | 35 (37.63) | 58 (62.37) | ||
| ≥5 cm | 60 | 16 (26.67) | 44 (73.33) | ||
| Unknown | 3 | ||||
| TNM stage | 9.710 | 0.008∗ | |||
| I | 79 | 30 (37.97) | 49 (62.03) | ||
| II | 66 | 21 (31.82) | 45 (68.18) | ||
| III | 11 | 0 (0.00) | 11 (100.00) | ||
| α-Fetoprotein (ng/ml) | 0.959 | 0.327 | |||
| <20 | 51 | 13 (25.49) | 38 (74.51) | ||
| ≥20 | 68 | 23 (33.82) | 45 (66.18) | ||
| Unknown | 37 | ||||
∗ p < 0.05.